HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jing Han Selected Research

cudraxanthone L

9/2021Cudraxanthone L inhibits gastric cancer by regulating the MAPK signalling and promoting FAS-mediated pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jing Han Research Topics

Disease

140Neoplasms (Cancer)
08/2022 - 03/2004
32Infections
12/2022 - 06/2008
27Neoplasm Metastasis (Metastasis)
05/2022 - 07/2007
27Inflammation (Inflammations)
03/2022 - 06/2010
26Stomach Neoplasms (Stomach Cancer)
01/2022 - 07/2012
25Breast Neoplasms (Breast Cancer)
08/2022 - 07/2010
23Type 2 Diabetes Mellitus (MODY)
12/2020 - 06/2011
19Body Weight (Weight, Body)
04/2022 - 08/2014
18Carcinogenesis
02/2022 - 12/2010
15Kashin-Beck Disease
10/2022 - 09/2012
15Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 01/2015
14Lung Neoplasms (Lung Cancer)
04/2022 - 01/2012
13Carcinoma (Carcinomatosis)
12/2021 - 08/2004
12Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 06/2015
11Obesity
06/2022 - 05/2013
10Pain (Aches)
12/2022 - 08/2007
10Osteoarthritis
10/2022 - 09/2012
10Cognitive Dysfunction
08/2022 - 01/2015
10Wounds and Injuries (Trauma)
05/2021 - 01/2012
9Hepatocellular Carcinoma (Hepatoma)
03/2022 - 10/2015
9Insulin Resistance
01/2022 - 06/2012
8Alzheimer Disease (Alzheimer's Disease)
01/2021 - 01/2015
8Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 01/2017
8Heart Failure
01/2019 - 07/2009
7Fibrosis (Cirrhosis)
06/2022 - 07/2009
7Diabetic Retinopathy (Retinopathy, Diabetic)
03/2021 - 01/2015
7Stroke (Strokes)
01/2019 - 11/2013
6Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 10/2016
6Infarction (Infarctions)
01/2022 - 10/2009
6Hypoxia (Hypoxemia)
10/2021 - 01/2013
6Ischemia
01/2021 - 09/2012
6Brain Ischemia (Cerebral Ischemia)
01/2019 - 09/2012
6Esophageal Neoplasms (Esophageal Cancer)
01/2018 - 01/2014
6Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2016 - 03/2004
5Glioblastoma (Glioblastoma Multiforme)
08/2022 - 03/2005
5Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 01/2019
5Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022 - 05/2013
5Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 04/2012
5Coronary Disease (Coronary Heart Disease)
01/2021 - 07/2009
5Hyperplasia
12/2019 - 04/2006
4Necrosis
07/2022 - 01/2013
4Fatty Liver
12/2021 - 01/2020
4Colitis-Associated Neoplasms
10/2021 - 06/2015
4Cardiovascular Diseases (Cardiovascular Disease)
05/2021 - 05/2012
4Esophageal Squamous Cell Carcinoma
02/2021 - 02/2016
4Adenoid Cystic Carcinoma (Cylindroma)
01/2021 - 01/2014
4Encephalitis (Encephalitis, Rasmussen)
01/2021 - 06/2018

Drug/Important Bio-Agent (IBA)

45Proteins (Proteins, Gene)FDA Link
07/2022 - 03/2005
41Biomarkers (Surrogate Marker)IBA
04/2022 - 07/2009
29Pharmaceutical PreparationsIBA
10/2022 - 12/2010
25Glucose (Dextrose)FDA LinkGeneric
01/2022 - 07/2009
23MicroRNAs (MicroRNA)IBA
01/2022 - 11/2013
19Messenger RNA (mRNA)IBA
01/2022 - 03/2005
17Long Noncoding RNAIBA
01/2021 - 01/2015
14Polysaccharides (Glycans)IBA
03/2022 - 01/2012
14Biological ProductsIBA
08/2021 - 07/2009
13Immunoglobulin G (IgG)IBA
03/2022 - 09/2012
12CytokinesIBA
12/2022 - 02/2010
12Peptides (Polypeptides)IBA
01/2022 - 07/2009
11Insulin (Novolin)FDA Link
01/2022 - 08/2003
11Therapeutic UsesIBA
01/2021 - 10/2006
9SeleniumIBA
10/2022 - 03/2016
9LipidsIBA
01/2022 - 05/2007
8Trastuzumab (Herceptin)FDA Link
08/2022 - 01/2018
8ErbB Receptors (EGF Receptor)IBA
04/2022 - 01/2015
8Glucagon-Like Peptide 1 (GLP 1)IBA
01/2022 - 11/2015
7CholesterolIBA
01/2022 - 01/2012
7Cisplatin (Platino)FDA LinkGeneric
09/2021 - 08/2009
7Blood Glucose (Blood Sugar)IBA
12/2020 - 05/2013
6DNA (Deoxyribonucleic Acid)IBA
03/2022 - 01/2013
6Phosphotransferases (Kinase)IBA
02/2022 - 12/2014
6Chondroitin Sulfates (Chondroitin Sulfate)IBA
12/2021 - 02/2013
6Anti-Bacterial Agents (Antibiotics)IBA
12/2020 - 06/2008
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2020 - 08/2011
6Histones (Histone)IBA
01/2020 - 10/2011
6CollagenIBA
01/2019 - 07/2009
6Tretinoin (Retinoic Acid)FDA LinkGeneric
10/2015 - 02/2005
5AntibodiesIBA
02/2022 - 01/2021
5Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2018
5Hypoglycemic Agents (Hypoglycemics)IBA
02/2021 - 01/2019
5Retinaldehyde (Retinal)IBA
11/2020 - 03/2012
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2020 - 08/2011
5RNA (Ribonucleic Acid)IBA
01/2020 - 06/2005
5CurcuminIBA
12/2019 - 05/2012
5AntioxidantsIBA
01/2019 - 06/2013
4Circular RNAIBA
02/2022 - 01/2020
4Amyloid (Amyloid Fibrils)IBA
01/2022 - 08/2011
4Triglycerides (Triacylglycerol)IBA
01/2022 - 03/2012
4CannabinoidsIBA
01/2022 - 01/2019
4InterferonsIBA
01/2022 - 01/2017
4Fatty Acids (Saturated Fatty Acids)IBA
12/2021 - 11/2015
4Peroxisome Proliferator-Activated Receptors (PPAR)IBA
12/2021 - 01/2015
4Neuroprotective AgentsIBA
12/2021 - 12/2015
4Aurora Kinase AIBA
01/2021 - 10/2020

Therapy/Procedure

54Therapeutics
08/2022 - 10/2006
12Drug Therapy (Chemotherapy)
04/2022 - 10/2014
12Immunotherapy
04/2022 - 01/2012
8Chinese Traditional Medicine (Traditional Chinese Medicine)
03/2022 - 09/2015
5Mastectomy (Mammectomy)
01/2022 - 07/2010
5Aftercare (After-Treatment)
01/2020 - 08/2014